Kallesøe Karen Hansen, Schröder Andreas, Jensen Jens Søndergaard, Wicksell Rikard K, Rask Charlotte Ulrikka
The Research Clinic for Functional Disorders and Psychosomatics Aarhus University Hospital Aarhus C Denmark.
Department of Clinical Medicine Aarhus University Aarhus N Denmark.
JCPP Adv. 2021 Dec 8;1(4):e12047. doi: 10.1002/jcv2.12047. eCollection 2021 Dec.
Evidence for treatment of adolescents with multiple functional somatic syndromes (FSS) is sparse. This study examined the efficacy of 'Acceptance and Commitment Therapy for Health in Adolescents' (AHEAD), a generic group-based treatment for adolescents with co-occurrence of multiple FSS.
A randomized trial was conducted at a specialized university hospital clinic. Adolescents (15-19 years) with multiple FSS of at least 1 year's duration were randomly assigned to AHEAD or enhanced usual care (EUC). AHEAD consisted of nine modules (i.e., 27 h) and one follow-up meeting. Primary outcome was physical health (SF-36). Various secondary outcomes and treatment targets were included (e.g., symptom severity, symptom impact, and illness perception). A linear mixed-effects model was used for analysis. Trial-registration: ClinicalTrials.gov NCT02346071.
Ninety-one patients were included. At 12 months, no significant difference in physical health was identified between groups (mean adjusted difference 1.2 [95% CI -1.6 to 4.0], = .404). However, different developments over time were seen with an interaction effect between intervention arm and time (χ(5) = 14.1, = .0148). AHEAD patients ( = 44) reported a clinically relevant improvement at end of treatment and at 8 and 12 months, while EUC patients ( = 47) displayed a clinically relevant improvement at 12 months. Furthermore, AHEAD patients showed a faster improvement on symptom severity, symptom impact and illness perception. EUC patients received more psychological treatment outside the trial ( ≤ .001) than AHEAD patients. Treatment satisfaction with AHEAD was high in contrast to EUC.
Compared with EUC, AHEAD had no additional advantage on the improvement of physical health at the primary endpoint of 12 months. However, a faster improvement of physical health was seen in AHEAD and considerably more psychological treatment was received outside the trial in EUC with clinically meaningful improvements in both groups. The results underpin the importance of an organised and systematic treatment offer for the most severely affected youth.
针对患有多种功能性躯体综合征(FSS)的青少年进行治疗的证据很少。本研究考察了“青少年健康接纳与承诺疗法”(AHEAD)的疗效,这是一种针对同时患有多种FSS的青少年的通用团体治疗方法。
在一家专业大学医院诊所进行了一项随机试验。将患有多种病程至少1年的FSS的青少年(15 - 19岁)随机分配至AHEAD组或强化常规护理(EUC)组。AHEAD包括九个模块(即27小时)和一次随访会议。主要结局指标为身体健康状况(SF - 36)。纳入了各种次要结局指标和治疗目标(例如症状严重程度、症状影响和疾病认知)。采用线性混合效应模型进行分析。试验注册信息:ClinicalTrials.gov NCT02346071。
共纳入91名患者。在12个月时,两组之间在身体健康状况方面未发现显著差异(平均调整差异为1.2 [95%可信区间 - 1.6至4.0],P = 0.404)。然而,随着时间推移观察到不同的变化情况,干预组与时间之间存在交互作用(χ(5) = 14.1,P = 0.0148)。AHEAD组患者(n = 44)在治疗结束时以及8个月和12个月时报告了具有临床意义的改善,而EUC组患者(n = 47)在12个月时显示出具有临床意义的改善。此外,AHEAD组患者在症状严重程度、症状影响和疾病认知方面改善更快。EUC组患者在试验外接受的心理治疗比AHEAD组患者更多(P ≤ 0.001)。与EUC组相比,对AHEAD组的治疗满意度较高。
与EUC组相比,在12个月的主要终点时,AHEAD组在改善身体健康状况方面没有额外优势。然而,AHEAD组的身体健康状况改善更快,且EUC组在试验外接受了更多的心理治疗,两组均有具有临床意义的改善。研究结果强调了为受影响最严重的青少年提供有组织、系统治疗的重要性。